Pacemakers Market Overview, Analysis And Demand By 2034

Created for forward-thinking professionals, this report equips teams with the insights needed to compete effectively in the pacemakers space.

Pacemakers Market Analysis & Forecast: 2025-2029
The pacemakers market size has grown steadily in recent years. It will grow from $5.42 billion in 2024 to $5.68 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to aging population, cardiovascular diseases, lifestyle-related health issues, regulatory approvals, heart attack survivors.

The pacemakers market size is expected to see strong growth in the next few years. It will grow to $7.76 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to telemedicine, public and private healthcare investment, pediatric and neonatal care, surgical techniques, miniaturization and leadless devices. Major trends in the forecast period include artificial intelligence (AI), wearable health tech, remote programming, electrophysiology procedures, technological advancements.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6593&type=smp

What Are The Factors Driving The Pacemakers Market?
The increasing prevalence of cardiovascular diseases is contributing to the growth of the pacemaker market going forward. Cardiovascular diseases refer to diseases that affect the heart and blood vessels. Drug discovery technologies are used to discover new drugs for cardiovascular diseases. Pacemakers include flexible and insulated wires that are helpful in controlling cardiovascular diseases by controlling irregular heart rhythms. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000, reflecting a 4.0% increase from last year's rate of 224.4 per 100,000, following a 4.6% rise in 2023, marking the first increase in these rates observed in many years. Therefore, the increasing prevalence of cardiovascular diseases will drive the growth of the pacemaker market.

What Segments Are Covered In The Pacemakers Market Report?
The pacemakersmarket covered in this report is segmented –

1) By Type: MRI Compatible Pacemaker; Conventional Pacemaker
2) By Technology: Single-Chamber Pacemaker; Dual-Chamber Pacemaker; Biventricular or CRT Pacemaker
3) By Implantability: Implantable Pacemaker; External Pacemaker
4) By Application: Congestive Heart Failure; Arrhythmias; Bradycardia; Tachycardia
5) By End-User: Hospitals; Cardiac Care Centers; Ambulatory Surgical Centers; Other End Users

Subsegments:
1) By MRI Compatible Pacemaker: Single-Chamber MRI Compatible Pacemaker; Dual-Chamber MRI Compatible Pacemaker; Biventricular MRI Compatible Pacemaker
2) By Conventional Pacemaker: Single-Chamber Conventional Pacemaker; Dual-Chamber Conventional Pacemaker; Biventricular Conventional Pacemaker

What Are The Main Trends, Positively Impacting The Growth Of Pacemakers Market?
Major companies operating in the pacemaker market are developing innovative products such as leadless pacemakers to meet larger customer bases, more sales, and increase revenue. Leadless pacemakers are a type of cardiac implantable electronic device (CIED) used to regulate the heartbeat and treat certain heart rhythm disorders. For instance, in July 2023, Abbott, a US-based medical device company, announced the U.S. Food and Drug Administration (FDA) approval for the AVEIR dual chamber (DR) leadless pacemaker system. With more than 80% of individuals requiring a pacemaker needing dual-chamber pacing (simultaneous pacing of both the right atrium and right ventricle), this approval significantly expands access to leadless pacing for millions of people in the United States. AVEIR DR devices, enabled by Abbott's proprietary i2i communication technology, offer synchronized or coordinated cardiac pacing between two leadless pacemakers based on a patient's clinical requirements. The i2i technology operates by employing high-frequency pulses to transmit messages through the body's naturally conductive blood, linking each leadless pacemaker. To facilitate dual-chamber therapy, each implant engages in real-time communication with its co-implanted counterpart, ensuring effective and synchronized cardiac pacing.

Which Are The Major Players Operating In The Global Pacemakers Market?
Major companies operating in the pacemakers market include Boston Scientific Corporation, ZOLL Medical Corporation, Medtronic plc Biotronik Medical Devices India Pvt ltd., MicroPort Scientific Corporation, Cook Medical Incorporated, MEDICO S.p.A., Shree Pacetronix Ltd., Oscor Inc., Osypka Medical GmbH, Abbott Laboratories, LivaNova PLC, Lepu Medical Technology(Beijing)Co Ltd., Cordis Inc., Vitatron Holding B.V., Integer Holdings Corporation, Zoll Medical Corporation, Synapse Biomedical Inc., Pacetronix Limited, Sorin Group Italia S.r.l., Galix Biomedical Instrumentation Inc., Imricor Medical Systems Inc., Sterimed Group, Edwards Lifesciences Corporation, SMT Medical GmbH & Co. KG, Spacelabs Healthcare Inc., BioTrace Medical Inc.

View the full pacemakers market report here:
https://www.thebusinessresearchcompany.com/report/pacemakers-global-market-report

Pacemakers Market Regional Insights:
North America was the largest region in the pacemaker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pacemakers market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company